Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Commences Note Exchange Offer

NEW YORK (GenomeWeb News) – Bio-Rad today said that it has commenced an exchange offer to exchange up to $300 million aggregate principal amount of its 8 percent senior subordinated notes due 2016 for any and all of its outstanding 8 percent senior subordinated notes due 2016 that were issued in a private placement.

Bio-Rad said that the sole purpose of the exchange offering is to fulfill its obligations with regard to the registration of the private notes. Any private notes that are not tendered for exchange in the offer will remain outstanding and continue to accrue interest, said Bio-Rad.

Bio-Rad announced the $300 million private placement of notes last spring.

The exchange offer will expire at 5:00 PM, New York City time, on Jan. 28, 2010, unless it is extended.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.